This company seems to have been delisted
Reason: Acquired by EQT-led Consortium
Last recorded trade on: March 19, 2024
Source: https://www.loyensloeff.com/insights/news--events/news/eqt-led-consortium-acquires-dechra-pharmaceuticals-plc/
Reason: Acquired by EQT-led Consortium
Last recorded trade on: March 19, 2024
Source: https://www.loyensloeff.com/insights/news--events/news/eqt-led-consortium-acquires-dechra-pharmaceuticals-plc/
Dechra Pharmaceuticals
DPH.L
$70.63
Share price
0.05%
Change (1 day)
64.47%
Change (1 year)
Categories
Dechra Pharmaceuticals (DPH.L) - P/B ratio
P/B ratio as of March 2025 : 5.88
According to Dechra Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 5.82676.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Dechra Pharmaceuticals - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 5.88 | 66.17% |
| 2022-12-31 | 3.54 | -60.81% |
| 2021-12-31 | 9.03 | 51.35% |
| 2020-12-31 | 5.97 | -4.63% |
| 2019-12-31 | 6.26 | 48.53% |
| 2018-12-31 | 4.21 | -31.86% |
| 2017-12-31 | 6.18 | 42.74% |
| 2016-12-31 | 4.33 | -7.73% |
| 2015-12-31 | 4.69 | 29.41% |
| 2014-12-31 | 3.63 | 20.61% |
| 2013-12-31 | 3.01 | -7.76% |
| 2012-12-31 | 3.26 | -8.63% |
| 2011-12-31 | 3.57 | -1.25% |
| 2010-12-31 | 3.61 | -4.59% |
| 2009-12-31 | 3.79 | 33.09% |
| 2008-12-31 | 2.84 | -50.74% |
| 2007-12-31 | 5.77 | 9.61% |
| 2006-12-31 | 5.27 | -21.05% |
| 2005-12-31 | 6.67 | 0.18% |
| 2004-12-31 | 6.66 | -5.04% |
| 2003-12-31 | 7.01 | -17.41% |
| 2002-12-31 | 8.49 |